Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients

NCT03324776 is registered in ClinicalTrials.gov with Model Clinical Research LLC as lead sponsor.

NCT NCT03324776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03324776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients
Lead sponsor
Model Clinical Research LLC
Phase
Phase 3
Overall status
Completed
Start date
October 16, 2017
Completion date
June 10, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes